Product Information

BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG CAPSULE is a generic product labeled by Lannett Company Inc., priced at $1.3780 per EA under NDC 00527409437. Its NADAC has been published 351 times since Mar 4, 2020.

FDA first approved this application on Dec 17, 2019. Its Orange Book therapeutic-equivalence code is AA.

BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG CAPSULE

butalbital, acetaminophen and caffeine
$1.3780per EA

Strength

325; 50; 40 mg/1; mg/1; mg/1

NDC

00527409437

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

11/18/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA212083

FDA Approved

12/17/2019

TE Code

AA

On Market Since

12/17/2019

Pharmacological Classes

Barbiturate
Barbiturates
Central Nervous System Stimulant
Central Nervous System Stimulation
Methylxanthine
Xanthines

Price Statistics

The NADAC for BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG CAPSULE has been published 351 times since Mar 4, 2020, and over the history we have for it it has declined 60.7%. The table below summarizes its recorded NADAC range and movement.

Current price$1.3780 per EA
All-time high$3.5968 (Jun 10, 2020)
All-time low$1.3780 (Nov 18, 2026)
52-week high$2.2534
52-week low$1.3780
Median price$2.6767
Average price$2.6856
Largest weekly change+37.8% (Jun 19, 2024)
Weeks tracked351
Tracking sinceMar 4, 2020

Price History

1W

-16.2%

1M

-28.6%

3M

-31.4%

6M

-20.4%

1Y

-38.1%

3Y

-49.5%

5Y

-58.0%

All

-60.7%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG CAPSULE, manufactured by Lannett Company Inc., is $1.3780 per EA (NDC 00527409437), effective Nov 18, 2026.

How has the price of BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG CAPSULE has declined 60.7%. It has been tracked across 351 weekly CMS publications since Mar 4, 2020.

What are the highest and lowest recorded NADAC prices for BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG CAPSULE?

Since Mar 4, 2020, the NADAC for BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG CAPSULE has ranged from a low of $1.3780 (Nov 18, 2026) to a high of $3.5968 (Jun 10, 2020), with a median of $2.6767 per EA.

Are there cheaper alternatives to BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG CAPSULE?

3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG CAPSULE in a comparable dosage form, but none are currently priced below it.

Who manufactures BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG CAPSULE?

BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG CAPSULE (NDC 00527409437) is labeled by Lannett Company Inc., and CMS classifies it as a generic product.